Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 63   

Articles published

ARNA 4.32 +0.28 (6.93%)
price chart
Is Arena The Next Alexion?
There was so much promise for the company and their recently approved drug Provenge that the valuation reached $6B for the company even before the product could hit the market. Many believers held the stock based on their ... Even though Alexion ...
Related articles »  
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Fights for Share of Weight-loss Pill ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA, ARNA message board) is expected to launch its patented Belviq treatment early next year, but there are some doubts that by that time Vivus, Inc. (NASDAQ:VVUS) will have made its Qsymia something of a ...
Related articles »  
Acadia Pharmaceuticals Poised For 100% Gain By December
... a company's prospects and affording investors willing to look beyond the conventional thinking an opportunity for substantial gains can be found in the positive advisory committee vote and subsequent approval of Arena Pharmaceuticals' (NASDAQ:ARNA) ...
Heroes And Zeros: Arena Pharmaceuticals And Avanir Pharmaceuticals
Arena Pharmaceuticals is a clinical stage biopharmaceutical company that has discovered, developed, and moved the first anti-obesity drug through FDA approval in the last 13 years in June of 2012.
Arena: DEA Schedule IV Will Make Belviq The Obesity Blockbuster Drug
In addition, Arena comes with some enticing benefits for a pharmaceutical suitor - 10 year Swiss Tax Haven and R&D Write-offs.
Related articles »  
Obesity Drugs Gain Attention on FDA Backing for Therapies
Third Rock Ventures is an early backer of Zafgen Inc., a biotechnology company in mid-stage trials of a therapy to treat obesity. The Food and Drug Administration cleared Belviq, from Arena Pharmaceuticals Inc. and Eisai Co., in June and Vivus Inc.'s ...
Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold ...  Forbes
All Eyes On Vivus As Weight Loss Drug Hits Market  YCharts
Related articles »  
Are Your Savings Ready to Retire, Too?
The road to a comfortable retirement isn't always smooth. In fact, it can get pretty bumpy along the way. Retirement planning is no easy task, but with the right tools and the right planning, you can dramatically increase the odds of long-term ...
Related articles »  
Promentis receives grant to develop schizophrenia drugs
Milwaukee-based Promentis Pharmaceuticals Inc. has received a three-year, $1.8 million award from the National Institutes of Health to develop more effective drugs to treat schizophrenia.
Fitness Tools for Kids and Gourmet Food Delivery
A portable fitness tool makes a game out of staying fit - and it's made just for kids. This free apps wants you to find other free apps, which is good news to your budget.
Life Insurance if You Have Student Loans
"It is best if you can name the person who will be responsible for your student loan debt as the beneficiary because then that individual will be paid outright by the insurance company if you pass away," Ian says. "You can always change the beneficiary ...
Related articles »